Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Pediatrics and Neonatology|April 20, 2013
Clinical features of Mycoplasma pneumoniae infections in the 2010 epidemic season: report of two cases with unusual presentationsTomoaki Takei, Miyuki Morozumi, Hirohiko Ozaki, et al.
Modern Rheumatology|August 28, 2014
Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritisToshitaka Kizawa, Tomo Nozawa, Masako Kikuchi, et al.
Modern Rheumatology|August 22, 2024
Nationwide epidemiological survey of juvenile idiopathic arthritis during transition to young adulthood in Japan using the National Database of Designated Incurable Diseases of JapanYuzaburo Inoue, Ryoko Sakai, Eisuke Inoue, et al.
Ryumachi. [Rheumatism]|November 6, 2003
[Effects of therapies on childhood systemic lupus erythematosus]Rumiko Kurosawa, Remi Umezawa, Yoshinori Kobayashi, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 6, 2009
[Infliximab for a girl with refractory pyoderma gangrenosum]Tomo Nozawa, Ryoki Hara, Jumpei Kinoshita, et al.
Modern Rheumatology|October 11, 2011
Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritisRemi Ozawa, Yutaka Inaba, Masaaki Mori, et al.
Modern Rheumatology|December 17, 2021
Transitioning from paediatric to adult rheumatological healthcare: English summary of the Japanese Transition Support GuideMasaaki Mori, Shinji Akioka, Toru Igarashi, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|March 1, 2013
[Chronic recurrent multifocal osteomyelitis with interstitial myositis]Saori Nagashima, Tomo Nozawa, Toshitaka Kizawa, et al.
The Journal of Rheumatology|May 3, 2014
Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritisChie Aoki, Yutaka Inaba, Hyonmin Choe, et al.
Modern Rheumatology|June 14, 2011
Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritisTomoyuki Imagawa, Shumpei Yokota, Masaaki Mori, et al.
Pageof 13